Pfizer Inc. (NYSE:PFE) ratings during last week

0
203
Stock, Trading, Shares

Investors sentiment for Pfizer Inc. (NYSE:PFE) decreased to 1.13 in 2016 Q4. This means that it is down 0.05, from 1.18 in 2016Q3.

It worsened, as 60 investors sold Pfizer Inc. shares while 672 reduced holdings. 115 funds opened positions while 711 raised stakes. 4.12 billion shares or 1.11% more from 4.08 billion shares in 2016Q3 were reported.

Among 20 analysts covering Pfizer (NYSE:PFE), 7 have Buy rating, 1 Sell and 12 Hold. Therefore 35% are positive. Pfizer had 55 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, June 14 by Jefferies. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Cowen & Co on Monday, August 14. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Wednesday, August 16 by Jefferies. The company was maintained on Wednesday, October 28 by S&P Research. The rating was maintained by Jefferies on Monday, June 20 with “Buy”. The rating was maintained by BMO Capital Markets with “Hold” on Friday, April 28. Berenberg initiated Pfizer Inc. (NYSE:PFE) rating on Thursday, May 12. Berenberg has “Hold” rating and $38 target. The rating was maintained by Jefferies on Thursday, July 14 with “Buy”. The rating was maintained by Jefferies on Tuesday, September 13 with “Buy”. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) on Friday, August 14 with “Buy” rating. Below is a list of Pfizer Inc. (NYSE:PFE) latest ratings and price target changes.

Argent Capital Management Limited Com stated it has 663,499 shares or 0.88% of all its holdings. M Kraus And invested in 0.51% or 23,168 shares. Shell Asset Mgmt owns 1.20 million shares. Granite Investment Advsrs stated it has 0.04% of its portfolio in Pfizer Inc. (NYSE:PFE). Renaissance Inv Ltd Co owns 37,825 shares for 0.58% of their portfolio. Df Dent And has invested 0.03% in Pfizer Inc. (NYSE:PFE). Bsw Wealth Prns reported 12,705 shares. Kcg Inc has 101,434 shares for 0.08% of their portfolio. Benin Mgmt Corporation owns 14,480 shares for 0.22% of their portfolio. Horan Capital Ltd accumulated 6,542 shares or 0.16% of the stock. Daiwa Secs Gru Inc holds 0.07% or 314,511 shares. Affinity Advsrs Limited Liability reported 680,687 shares stake. Pictet North America holds 0.06% of its portfolio in Pfizer Inc. (NYSE:PFE) for 8,293 shares. Davy Asset Mgmt Limited invested in 2.91% or 429,635 shares. 4,325 are owned by Lipe & Dalton.

05/09/2017 Broker: BMO Capital Markets Rating: Buy New Target: $37.0 Maintain
16/08/2017 Broker: Jefferies Rating: Hold New Target: $35.0 Maintain
14/08/2017 Broker: Berenberg Rating: Hold New Target: $36.0
14/08/2017 Broker: Cowen & Co Rating: Buy New Target: $43.0000 Maintain
02/08/2017 Broker: Piper Jaffray Rating: Buy New Target: $52.0000 Maintain
01/08/2017 Broker: BMO Capital Markets Rating: Hold New Target: $33.0000 Maintain
20/07/2017 Broker: Credit Suisse Old Rating: Outperform New Rating: Neutral Downgrade
13/07/2017 Broker: Jefferies Rating: Hold New Target: $35.0000 Maintain
10/07/2017 Broker: Cowen & Co Rating: Buy New Target: $43.0000 Maintain
12/06/2017 Broker: BMO Capital Markets Rating: Hold New Target: $33.0000 Maintain

About 11.30M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since September 11, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Pfizer Inc. is a research-based global biopharmaceutical company. The company has market cap of $204.32 billion. The Firm is engaged in the discovery, development and manufacture of healthcare products. It has a 24.99 P/E ratio. The Company’s global portfolio includes medicines and vaccines, as well as consumer healthcare products.

LEAVE A REPLY

Please enter your comment!
Please enter your name here